•  635
    Property in the Body: Feminist Perspectives
    Cambridge University Press. 2007.
    New developments in biotechnology radically alter our relationship with our bodies. Body tissues can now be used for commercial purposes, while external objects, such as pacemakers, can become part of the body. Property in the Body: Feminist Perspectives transcends the everyday responses to such developments, suggesting that what we most fear is the feminisation of the body. We fear our bodies are becoming objects of property, turning us into things rather than persons. This book evaluates how w…Read more
  •  329
    'An alarming and illuminating book. The story of how we have allowed private corporations to patent genes, to stockpile human tissue, and in short to make profits out of what many people feel ought to be common goods is a shocking one. No one with any interest at all in medicine and society and how they interact should miss this book, and it should be required reading for every medical student,'--Philip Pullman
  •  327
    Healthcare Ethics and Human Values: An Introductory Text with Readings and Case Studies (edited book)
    with K. W. M. Fulford and Thomas H. Murray
    Wiley-Blackwell. 2002.
    This volume illustrates the central importance of diversity of human values throughout healthcare. The readings are organized around the main stages of the clinical encounter from the patient's perspective. They run from staying well and 'first contact' through to either recovery or to long-term illness, death and dying
  •  260
    Even in the increasingly individualized American medical system, advocates of 'personalized medicine' claim that healthcare isn't individualized enough. With the additional glamour of new biotechnologies such as genetic testing and pharmacogenetics behind it, 'Me Medicine'-- personalized or stratified medicine-- appears to its advocates as the inevitable and desirable way of the future. Drawing on an extensive evidence base, this book examines whether these claims are justified. It goes on to ex…Read more
  •  220
    Can children withhold consent to treatment
    with John Devereux and D. P. H. Jones
    British Medical Journal 306 (6890): 1459-1461. 1993.
    A dilemma exists when a doctor is faced with a child or young person who refuses medically indicated treatment. The Gillick case has been interpreted by many to mean that a child of sufficient age and intelligence could validly consent or refuse consent to treatment. Recent decisions of the Court of Appeal on a child's refusal of medical treatment have clouded the issue and undermined the spirit of the Gillick decision and the Children Act 1989. It is now the case that a child patient whose comp…Read more
  •  218
    The new French resistance: commodification rejected?
    Medical Law International 7 (1): 41-63. 2005.
    In this article I evaluate a resurrected French resistance movement--to biotechnological commodification. The official French view that ‘the body is the person’ has been dismissed as a ‘taboo’ by the French political scientist Dominique Memmi . Yet France has indeed resisted the models of globalised commodification adopted in US bioechnology, as, for example, when the government blocked a research collaboration between the American firm Millennium Pharmaceuticals and a leading genomics laborator…Read more
  •  201
    Personalised Medicine, Individual Choice and the Common Good (edited book)
    with Britta van Beers and Sigrid Sterckx
    Cambridge University Press. 2018.
    This is a volume of twelve essays concerning the fundamental tension in personalised medicine between individual choice and the common good.
  •  195
    This book contributes to the feminist reconstruction of political theory. Although many feminist authors have pointed out the ways in which women have been property, they have been less successful in suggesting how women might become the subjects rather than the objects of property-holding. This book synthesises political theory from liberal, Marxist, Kantian and Hegelian traditions, applying these ideas to history and social policy.
  •  183
    Nurse time as a scarce health care resource
    In Geoffrey Hunt (ed.), Ethical issues in nursing, Routledge. pp. 207-217. 1994.
    For a long time, discussion about scarce health care resource allocation was limited to allocation of medical resources, with the paradigmatic case being kidney transplants. This narrow focus on medical resource prevents us from seeing that there are many cases-- perhaps even the majority--in which time is the real scarce resource, particularly nurse time. What ethical principles should apply to nurse time as a scarce health care resource?
  •  170
    Death, Dying and Bereavement (edited book)
    with Malcolm Johnson and Jeanne Samson Katz
    Sage. 1993.
    Collection of essays, literature and first-person accounts on death, dying and bereavement.
  •  159
    Editorial: Mental Capacity: In Search of Alternative Perspectives
    with Berghmans Ron and Meulen Ruud Ter
    Health Care Analysis 12 (4): 251-263. 2004.
    Editorial introduction to series of papers resulting from a European Commission Project on mental capacity
  •  154
    Review of collection of papers, primarily concerning the Phillipines, edited by H.T. Engelhardt and introduced by E. Pellegrino.
  •  148
    Philosophical assumptions and presumptions about trafficking for prostitution
    In Christien van den Anker & Jeroen Doomernik (eds.), Trafficking and women's rights, Palgrave Macmillan. pp. 43-54. 2006.
    This chapter critically examines two frequently found assumptions in the debate about trafficking for prostitution: 1. That the sale of sexual services is like the sale of any other good or service; 2. That by and large women involved in trafficking for prostitution freely consent to sell such services.
  •  139
    Who owns embryonic and fetal tissue?
    In Ethical Issues in Maternal-Fetal Medicine, Cambridge University Press. pp. 233-244. 2002.
    Until very recently the question of who owns embryonic or fetal tissue was of limited importance to clinicians, but advances in stem cell research have made such tissue commercially valuable. This chapter examines the legal and ethical basis of claims to property in embryonic or fetal tissue, taking a critical stance.
  •  136
    In Two Minds: A Casebook of Psychiatric Ethics
    with Bill Fulford and K. W. M. Fulford
    Oxford University Press. 2000.
    In Two Minds is a practical casebook of problem solving in psychiatric ethics. Written in a lively and accessible style, it builds on a series of detailed case histories to illustrate the central place of ethical reasoning as a key competency for clinical work and research in psychiatry. Topics include risk, dangerousness and confidentiality; judgements of responsibility; involuntary treatment and mental health legislation; consent to genetic screening; dual role issues in child and adolescent p…Read more
  •  135
    What should be the RCOG's relationship with older women?
    In Susan Bewley, William Ledger & Dimitrios Nikolaou (eds.), Reproductive Ageing, Royal College of Obstetricians and Gynaecologists. pp. 277-286. 2009.
    Reproductive ageing has effects on individual and public health, now and in generations to come. This volume of presentations from a conference at the Royal College of Obstetricians and Gynaecologists brings together a diverse but timely set of contributions.. in ny chapter I specifically examine the responsibilities of the College to women outside normal reproductive age.
  •  134
    To assess whether UK and US health care professionals share the views of medical ethicists about medical futility, withdrawing/withholding treatment, ordinary/extraordinary interventions, and the doctrine of double effect. A 138-item attitudinal questionnaire completed by 469 UK nurses studying the Open University course on "Death and Dying" was compared with a similar questionnaire administered to 759 US nurses and 687 US doctors taking the Hastings Center course on "Decisions near the End of L…Read more
  •  134
    The spread of liberal individualism to the family is often portrayed as deeply inimical to the welfare of children and young people. In this view, the family is the bastion of the private and the antithesis of the contractual, rights-oriented model that underpins public life. This chapter examines that proposition critically.
  •  130
    Review of Mary Mahowald, Genes, Women, Equality
  •  129
    Ownership, property and women's bodies
    In Heather Widdows, Aitsiber Emaldi Cirion & Itziar Alkorta Idiakez (eds.), Women's Reproductive Rights, Palgrave Macmillan. pp. 188-198. 2006.
    Does advocating women's reproductive rights require us to believe that women own property in their bodies? In this chapter I conclude that it does not. Although the concept of owning our own bodies — ‘whose body is it anyway?’ — has polemical and political utility, it is incoherent in philosophy and law. Rather than conflate the entirely plausible concept of women’s reproductive rights and the implausible notion of property in the body, we should keep them separate, so that the weakness of the s…Read more
  •  125
    The Lady Vanishes: What’s Missing from the Stem Cell Debate
    Journal of Bioethical Inquiry 3 (1): 43-54. 2006.
    Most opponents of somatic cell nuclear transfer and embryonic stem cell technologies base their arguments on the twin assertions that the embryo is either a human being or a potential human being, and that it is wrong to destroy a human being or potential human being in order to produce stem cell lines. Proponents’ justifications of stem cell research are more varied, but not enough to escape the charge of obsession with the status of the embryo. What unites the two warring sides in ‘the stem ce…Read more
  •  125
    This book examines the moral luck paradox, relating it to Kantian, consequentialist and virtue-based approaches to ethics. It also applies the paradox to areas in medical ethics, including allocation of scarce medical resources, informed consent to treatment, withholding life-sustaining treatment, psychiatry, reproductive ethics, genetic testing and medical research. If risk and luck are taken seriously, it might seem to follow that we cannot develop any definite moral standards, that we are doo…Read more
  •  125
    Disappearing women, vanishing ladies and property in embryos
    International Journal of Law and the Biosciences 4 1-6. 2017.
    Guidelines on embryo storage prioritise 'respect for the embryo' above the wishes of the women whose labour and tissue have gone into creating the embryo in the first place, effectively making women and the female body disappear. In this article I draw a parallel between this phenomenon relating to embryo storage and other instances of a similar phenomenon that I have called 'the lady vanishes', particularly in stem cell and 'mitochondrial transfer' research. I suggest that a modified property r…Read more
  •  123
    Regulating (or not) reproductive medicine: an alternative to letting the market decide
    Indian Journal of Medical Ethics 8 (3): 175-179. 2011.
    Whilst India has been debating how to regulate 'surrogacy' the UK has undergone a major consultation on increasing the amount of 'expenses'paid to egg 'donors', while France has recently finished debating its entire package of bioethics regulation and the role of its Biomedicine Agency. Although it is often claimed that there is no alternative to the neo-liberal, market-based approach in regulating (or not) reproductive medicine--the ideology prevalent in both India and the UK--advocates of that…Read more
  •  120
    Review of Nils Hoppe, Bioequity--Property and the Human Body (review)
    International Journal of Law in Context 6 (4): 397-399. 2010.
    Review of Nils Hoppe book, Bioequity--Property in the Body
  •  119
    Ethical qualms about genetic prognosis
    Canadian Medical Association Journal 188 (6): 1-2. 2016.
    The debate about direct-to-consumer genetic testing has centred on whether consumers are the best judges of their own clinical care. Inthis article, I also examine whether the science of personalized medicine is really as advanced as its proponents claim, and how the availability of genetic markers affects decisions on who gets and does not get medical treatment.
  •  118
    Decision-making competence in adults: a philosopher's viewpoint
    Advances in Psychiatric Treatment 7 (5): 381-387. 2001.
    What does it mean to respect autonomy and encourage meaningful consent to treatment in the case of patients who have dementia or are otherwise incompetent? This question has been thrown into sharp relief by the Law Lords' decision in R.v Bournewood Community and Mental Health NHS Trust, ex parte L.
  •  118
    Testing times for the consumer genetics revolution
    The New Scientist 221 (2251): 26-27. 2014.
    With the highest profile seller of $99 genetic tests under fire, will public trust in personalised medicine suffer?